Market Overview

Align Technology CEO Defends Q2 Results, Highlights Bright Future

Align Technology CEO Defends Q2 Results, Highlights Bright Future

Shares of Align Technology, Inc. (NASDAQ: ALGN) — maker of Invisalign — plummeted Thursday in reaction to the company's second-quarter earnings report and guidance but CEO Joe Hogan remains "optimistic about the market."

What Happened

On top of reporting an earnings miss in the quarter, Align shipped 377,100 of its core Invisalign cases which fell 5,800 units short of expectations. Hogan told CNBC's Jim Cramer Thursday much of the weakness can be attributed to China.

China is Invisalign's second largest market and the company hoped to see 70% growth in the second quarter, the CEO told Cramer. But Thursday's report showed just 20%-30% growth and the weakness is not due to any competitive or operational issues.

"It's just basically a consumer backlash right now, we feel, from a standpoint of making decisions on going ahead with aligners or not," Hogan said.

Outside of China, the company saw notable strength across Europe at 39% and a triple-digit growth rate in markets like Brazil.

Why It's Important

Hogan said he was in Asia for first-hand checks and there is no sign his company is losing market share despite a growing competitive market. In fact, Hogan said he saw higher levels of orders throughout July in China, and encouragingly, also in the U.S. market.

Shares of Align plummeted nearly 30% Thursday and Hogan said the company has around $400 million in remaining share buyback authorization. As such, the company will "certainly take advantage" of its position and when asked by Cramer if he will personally be buyer of the stock the CEO responded "I think you will see that also."

"There is a broad based growth story here," he said. "I have to do a better job and the company has to do a better job of getting out. It's not necessarily a competitive story, it's an opportunity story for us overall."

The stock traded around $198 per share at time of publication.

Related Links

Benzinga's Top Upgrades, Downgrades For July 25, 2019

Align Tech Faces Slowing Growth, Potential Headwinds, Morgan Stanley Says In Downgrade

Posted-In: China CNBCEarnings News Guidance Health Care Media General Best of Benzinga


Related Articles (ALGN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Mid-Afternoon Market Update: eHealth Surges After Strong Q2 Results; Neuralstem Shares Drop

A Step Forward: Drive Wealth, Vested Finance Democratize Financial Markets